Neuroprotective and Neurogenic Properties of Dehydroepiandrosterone and its Synthetic Analogs

Hormones in Neurodegeneration, Neuroprotection, and Neurogenesis

Volumn , Issue , 2011, Pages 137-154

  Charalampopoulos, Ioannis ^a   Lazaridis, Iakovos ^a   Gravanis, Achille ^a  

^a UNIVERSITY OF CRETE   (Greece)

Author keywords

Cytoprotective effects of DHEA; DHEA; DHEAS; Fluasterone; Neurogenic effects of DHEA; Neuroprotective effects of DHEA

Indexed keywords

EID: 84883269193     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9783527633968.ch8     Document Type: Chapter

References (110)

1. Corpechot, C., Robel, P., Axelson, M., Sjovall, J., and Baulieu, E.E. (1981) Characterization and measurement of dehydroepiandrosterone sulfate in rat brain. Proc. Natl. Acad. Sci. U.S.A., 78, 4704-4707.
2. Baulieu, E.E. (1997) Neurosteroids: of the nervous system, by the nervous system, for the nervous system. Recent Prog. Horm. Res., 52, 1-32.
3. Miller, W.L. (2002) Androgen biosynthesis from cholesterol to DHEA. Mol. Cell. Endocrinol., 198, 7-14.
4. Mellon, S.M. (2001) Biosynthesis of neurosteroids and regulation of each synthesis. Int. Rev. Neurobiol., 46, 33-78.
5. Compagnone, N.A., Bulfone, A., Rubenstein, J.L., and Mellon, S.H. (1995) Steroidogenic enzyme P450c17 is expressed in the embryonic central nervous system. Endocrinology, 136, 5212-5223.
6. Kohchi, C., Ukena, K., and Tsutsui, K.B. (1998) Age- and region-specific expressions of the messenger RNAs encoding for steroidogenic enzymes P450scc, P450c17 and 3b-HSD in the postnatal rat brain. Brain Res., 801, 233-238.
7. Zwain, I. and Yen, S. (1999) Neurosteroidogenesis in astrocytes, oligodendrocytes, and neurons of cerebral cortex of rat brain. Endocrinology, 140, 3843-3852.
8. Zwain, I. and Yen, S. (1999) Dehydroepiandrosterone: biosynthesis and metabolism in the brain. Endocrinology, 140, 880-887.
9. Kibaly, K., Patte-Mensah, C., and Mensah-Nyagan, A. (2005) Molecular and neurochemical evidence for the biosynthesis of dehydroepiandrosterone in the adult rat spinal cord. J. Neurochem., 93, 1220-1230.
10. Mukai, H., Takata, N., Ishii, H., Tanabe, N., Hojo, Y., Furukawa, A., Kimoto, T., and Kawato, S. (2006) Hippocampal synthesis of estrogens and androgens which are paracrine modulators of synaptic plasticity: synaptocrinology. Neuroscience, 138, 757-764.
11. Hojo, Y., Hattori, T.A., Enami, T., Furukawa, A., Suzuki, K., Ishii, H.-T., Mukai, H., Morrison, J.-H., Janssen, W.-G., Kominami, S., Harada, N., Kimoto, T., and Kawato, S. (2004) Adult male rat hippocampus synthesizes estradiol from pregnenolone by cytochromes P45017 alpha and P450 aromatase localized in neurons. Proc. Natl. Acad. Sci. U.S.A., 101, 865-870.
12. Do Rego, J.L., Tremblay, Y., Luu-The, V., Repetto, E., Castel, H., Vallarino, M., Belanger, A., Pelletier, G., and Vaudry, H. (2007) Immunohistochemical localization and biological activity of the steroidogenic enzyme cytochrome P450 17a-hydroxylase/C17, 20-lyase (P450C17) in the frog brain and pituitary. J. Neurochem., 100, 251-268.
13. Cascio, C., Brown, R.C., Liu, Y., Han, Z., Hales, D.B., and Papadopoulos, V. (2000) Pathways of dehydroepiandrosterone formation in rat brain glia. J. Steroid Biochem. Mol. Biol., 75, 177-186.
14. Brown, R.-C., Cascio, C., and Papadopoulos, V. (2000) Pathways of neurosteroid biosynthesis in cell lines from human brain: regulation of dehydroepiandrosterone formation by oxidative stress and beta-amyloid peptide. J. Neurochem., 74, 847-859.
15. Belanger, A., Candas, B., Dupont, A., Cusan, L., Diamond, P., Gomez, J.L., and Labrie, F. (1994) Changes in serum concentrations of conjugated and unconjugated steroids in 40- to 80-year-old men. J. Clin. Endocrinol. Metab., 79, 1086-1090.
16. Migeon, C.J., Keller, A.R., Lawrence, B., and Shepart, T. (1957) Dehydroepiandrosterone and androsterone levels in human placenta. Effects of age and sex: day-to-day and diurnal variations. J. Clin. Endocrinol. Metab., 17, 1051-1062.
17. Vermeulen, A., Deslypene, J.P., Schelthout, W., Verdonck, L., and Rubens, R. (1982) Adrenocortical function in old age: response to acute adrenocorticotropin stimulation. J. Clin. Endocrinol. Metab., 54, 187-191.
18. Charalampopoulos, I., Margioris, A., and Gravanis, A. (2008) Neurosteroid dehydroepiandrosterone exerts anti-apoptotic effects by membrane-mediated, integrated genomic and non-genomic pro-survival signaling pathways. J. Neurochem., 107, 1457-1469.
19. Compagnone, N.A. and Mellon, S.H. (2000) Neurosteroids: biosynthesis and function of these novel neuromodulators. Front. Neuroendocrinol., 21, 1-56.
20. Majewska, M.D., Demirgören, S., Spivak, C.E., and London, E. (1990) The neurosteroid dehydroepiandrosterone sulfate is an allosteric antagonist of the GABAA receptor. Brain Res., 526, 143-146.
21. Johansson, T. and Le Grevés, P. (2005) The effect of dehydroepiandrosterone sulfate and allopregnanolone sulfate on the binding of [(3)H]ifenprodil to the N-methyl-d-aspartate receptor in rat frontal cortex membrane. J. Steroid Biochem. Mol. Biol., 94, 263-266.
22. Maurice, T., Roman, F., Privat, A. and (1996) Modulation by neurosteroids of the in vivo (+)-[3H]SKF-10,047 binding to sigma 1 receptors in the mouse forebrain. J. Neurosci. Res., 46, 734-743.
23. Laurine, E., Lafitte, D., Grégoire, C., Sérée, E., Loret, E., Douillard, S., Michel, B., Briand, C., and Verdier, J.M. (2003) Specific binding of dehydroepiandrosterone to the N terminus of the microtubule-associated protein MAP2. J. Biol. Chem., 278, 29979-29986.
24. Pérez-Neri, I., Montes, S., Ojeda-López, C., Ramírez-Bermúdez, J., and Ríos, C. (2008) Modulation of neurotransmitter systems by dehydroepiandrosterone and dehydroepiandrosterone sulfate: Mechanism of action and relevance to psychiatric disorders. Prog. Neuropsychopharmacol. Biol. Psychiatry, 32, 1118-1130.
25. Lazaridis, I., Charalampopoulos, I., Vergou, V., Avlonitis, N., Calogeropoulou, T., and Gravanis, A. (2010) Neurosteroid dehydroepiandrosterone directly binds to NGF receptors, rescuing neuronal cells from apoptosis. FENS Abstracts 5, 112.7.
26. Weill-Engerer, S., David, J.P., Sazdovitch, V., Liere, P., Eychenne, B., Pianos, A., Schumacher, M., Delacourte, A., Baulieu, E.E., and Akwa, Y. (2002) Neurosteroid quantification in human brain regions: comparison between Alzheimer's and nondemented patients. J. Clin. Endocrinol. Metab., 87 (11), 5138-5143.
27. Schumacher, M., Weill-Engerer, S., Liere, P., Robert, F., Franklin, R.J., Garcia-Segura, L.M., Lambert, J.J., Mayo, W., Melcangi, R.C., Parducz, A., Suter, U., Carelli, C., Baulieu, E.E., and Akwa, Y. (2003) Steroid hormones and neurosteroids in normal and pathological aging of the nervous system. Prog. Neurobiol., 71, 3-29.
28. Li, L., Xu, B., Zhu, Y., Chen, L., and Sokabe, M. (2010) DHEA prevents Abeta(25-35)-impaired survival of newborn neurons in the dentate gyrus through a modulation of PI3K-Akt-mTOR signaling. Neuropharmacology, 59, 323-333.
29. Kato-Negishi, M. and Kawahara, M. (2008) Neurosteroids block the increase in intracellular calcium level induced by Alzheimer's beta-amyloid protein in long-term cultured rat hippocampal neurons. Neuropsychiatr. Dis. Treat., 4, 209-218.
30. Sinha, N., Baquer, N.-Z., and Sharma, D. (2005) Anti-lipidperoxidative role of exogenous dehydroepiendrosterone (DHEA) administration in normal ageing rat brain. Indian J. Exp. Biol., 43, 420-424.
31. Chen, C., Lang, S., Zuo, P., Yang, N., and Wang, X. (2008) Treatment with dehydroepiandrosterone increases peripheral benzodiazepine receptors of mitochondria from cerebral cortex in d-galactose-induced aged rats. Basic Clin. Pharmacol. Toxicol., 103, 493-501.
32. Bastianetto, S., Ramassamy, C., Poirier, J., and Quirion, R. (1999) Dehydroepiandrosterone (DHEA) protects hippocampal cells from oxidative stress-induced damage. Brain Res. Mol. Brain Res., 66, 35-41.
33. Kimonides, V.G., Khatibi, N.H., Svendsen, C.N., Sofroniew, M.V., and Herbert, J. (1998) Dehydroepiandrosterone (DHEA) and DHEA-sulfate (DHEAS) protect hippocampal neurons against excitatory amino acid-induced neurotoxicity. Neurobiology, 95, 1852-1857.
34. Kurata, K., Takebayashi, M., Morinobu, S., and Yamawaki, S. (2004) beta-estradiol, dehydroepiandrosterone, and dehydroepiandrosterone sulfate protect against N-methyl-D-aspartate-induced neurotoxicity in rat hippocampal neurons by different mechanisms. J. Pharmacol. Exp. Ther., 311, 237-245.
35. Cardounel, A., Regelson, W., and Kalimi, M. (1999) Dehydroepiandrosterone protects hippocampal neurons against neurotoxin-induced cell death: mechanism of action. Proc. Soc. Exp. Biol. Med., 222, 145-149.
36. Kimonides, V.G., Spillantini, M.G., Sofroniew, M.V., Fawcett, J.W., and Herbert, J. (1999) Dehydroepiandrosterone antagonizes the neurotoxic effects of corticosterone and translocation of stress-activated protein kinase 3 in hippocampal primary cultures. Neuroscience, 89 (2), 429-436.
37. Xilouri, M. and Papazafiri, P. (2008) Induction of Akt by endogenous neurosteroids and calcium sequestration in P19 derived neurons. Neurotox. Res., 13, 209-219.
38. Leskiewicz, M., Regulska, M., Budziszewska, B., Jantas, D., Jaworska-Feil, L., Basta-Kaim, A., Kubera, M., Jagla, G., Nowak, W. and Lason, W. (2008) Effects of neurosteroids on hydrogen peroxide- and staurosporine-induced damage of human neuroblastoma SH-SY5Y Cells 1. J. Neurosci. Res., 86, 1361-1370.
39. Budziszewska, B., Siwanowicz, J., Leokiewicz, M., Jaworska-Feil, L., and Lasoń, W. (1998) Protective effects of neurosteroids against NMDA-induced seizures and lethality in mice. Eur. Neuropsychopharmacol., 8, 7-12.
40. Alhaj, H.A., Massey, A.E., and McAllister-Williams, R.H. (2006) Effects of DHEA administration on episodic memory, cortisol and mood in healthy young men: a double-blind, placebo-controlled study. Psychopharmacology, 188, 541-551.
41. Zhang, X., Dong, Y., Yang, N., Liu, Y., Gao, R. and Zuo, P. (2007) Effects of ning shen ling granule and dehydroepiandrosterone on cognitive function in mice undergoing chronic mild stress. Chin. J. Integr. Med., 13, 46-49.
42. Flood, J.F., Smith, G.E., and Roberts, E. (1988) Dehydroepiandrosterone and its sulfate enhance memory retention in mice. Brain Res., 447, 269-278.
43. Urani, A., Privat, A., and Maurice, T. (1998) The modulation by neurosteroids of the scopolamine-induced learning impairment in mice involves an interaction with sigma 1 receptors. Brain Res., 799, 64-77.
44. Markowski, M., Ungeheuer, M., Bitran, D., and Locurto, C. (2001) Memory-enhancing effects of DHEAS in aged mice on a win-shift water escape task. Physiol. Behav., 72 (4), 521-525.
45. Chen, L., Dai, X.N., and Sokabe, M. (2006) Chronic administration of dehydroepiandrosterone sulfate (DHEAS) primes for facilitated induction of long-term potentiation via sigma 1 receptor: optical imaging study in rat hippocampal slices. Neuropharmacology, 50, 380-392.
46. Chen, L., Miyamoto, Y., Furuya, K., Dai, X.N., Mori, N., and Sokabe, M. (2006) Chronic DHEAS administration facilitates hippocampal long-term potentiation via an amplification of Src-dependent NMDA receptor signaling. Neuropharmacology, 51, 659-670.
47. Kaminska, M., Harris, J., Gijsbers, K., and Dubrovsky, B. (2000) Dehydroepiandrosterone sulfate (DHEAS) counteracts decremental effects of corticosterone on dentate gyrus LTP. Implications for depression. Brain Res. Bull., 52, 229-234.
48. Hajszan, T., MacLusky, N.J., and Leranth, C. (2004) Dehydroepiandrosterone increases hippocampal spine synapse density in ovariectomized female rats. Endocrinology, 145, 1042-1045.
49. MacLusky, N.J., Hajszan, T., and Leranth, C. (2004) Effects of dehydroepiandrosterone and flutamide on hippocampal CA1 spine synapse density in male and female rats: implications for the role of androgens in maintenance of hippocampal structure. Endocrinology, 145, 4154-4161.
50. Meyer, J., Lee, S., Wittenberg, G., Randall, R., and Gruol, D. (1999) Neurosteroid regulation of inhibitory synaptic transmission in the rat hippocampus in vitro. Neuroscience, 90, 1177-1183.
51. Meyer, J. and Gruol, D. (1994) Dehydroepiandrosterone sulfate alters synaptic potentials in area CA1 of the hippocampal slice. Brain Res., 633, 253-261.
52. Steffensen, S., Jones, M., Hales, K., and Allison, D. (2006) Dehydroepiandrosterone sulfate and estrone sulfate reduce GABArecurrent inhibition in the hippocampus via muscarinic acetylcholine receptors. Hippocampus, 16, 1080-1090.
53. Iwata, M., Muneoka, K.T., Shirayama, Y., Yamamoto, A., and Kawahara, R. (2005) A study of a dendritic marker, microtubule-associated protein 2 (MAP-2), in rats neonatally treated neurosteroids, pregnenolone and dehydroepiandrosterone (DHEA). Neurosci. Lett., 386, 145-149.
54. Karishma, K.K. and Herbert, J. (2002) Dehydroepiandrosterone (DHEA) stimulates neurogenesis in the hippocampus of the rat, promotes survival of newly formed neurons and prevents corticosterone-induced suppression. Eur. J. Neurosci., 16, 445-453.
55. Shirayama, Y., Muneoka, K., Iwata, M., Ishida, H., Hazama, G., and Kawahara, R. (2005) Pregnenolone and dehydroepiandrosterone administration in neonatal rats alters the immunoreactivity of hippocampal synapsin I, neuropeptide Y and glial fibrillary acidic protein at post-puberty. Neuroscience, 133, 147-157.
56. Lewis, S.J., and Barker, R.A. (2009) Understanding the dopaminergic deficits in Parkinson's disease: insights into disease heterogeneity. J. Clin. Neurosci., 16, 620-625.
57. Tatton, N. and Kish, J. (1997) In situ detection of apoptotic nuclei in the substantia nigra compacta of MPTP-treated mice using terminal deoxynucleotidyl transferase labelling and acridine orange staining. Neuroscience, 77, 1037-1048.
58. Kuhn, K., Wellen, J., Link, N., Maskri, L., Lubbert, H. and Stickel, C.C. (2003) The mouse MPTP model: gene expression changes to dopaminergic neurons. Eur. J. Neurosci., 17, 1-12.
59. Schmidt, N. and Ferger, B. (2001) Neurochemical findings in the MPTP model of Parkinson's disease. J. Neural Transm., 108, 1263-1282.
60. D'Astous, M., Morissette, M., Tanguay, B., Callier, S., and Di Paolo, T. (2003) Dehydroepiandrosterone (DHEA) such as 17beta-estradiol prevents MPTP-induced dopamine depletion in mice. Synapse, 47, 10-14.
61. Belanger, N., Gregoire, L., Bedard, P., and Di Paolo, T. (2006) DHEA improves symptomatic treatment of moderately and severely impaired MPTP monkeys. Neurobiol. Aging, 27, 1684-1693.
62. Bélanger, N., Grégoire, L., Bédard, J., and Di Paolo, T. (2003) Estradiol and dehydroepiandrosterone potentiate levodopa-induced locomotor activity in 1-methyl-4-phenyl-1,2,3,6 tetrahydropyridine monkeys. Endocrine, 21, 97-101.
63. Tomas-Camardiel, M., Sanchez-Hidalgo, M., Sanchez del Pino, M., Navarro, A., Machado, A., and Cano, J. (2002) Comparative study of the neuroprotective effect of dehydroepiandrosterone and 17 beta-estradiol against 1-methyl-4-phenylpyridinium toxicity on rat striatum. Neuroscience, 109, 569-584.
64. Kaasik, A., Kalda, A., Jaako, K., and Zharkowski, A. (2001) DHEAS prevents oxygen-glucose deprivation-induced injury in cerebellar granule cell cultures. Neuroscience, 102, 427-432.
65. Charalampopoulos, I., Dermitzaki, E., Vardouli, L., Tsatsanis, C., Stournaras, C., Margioris, A., and Gravanis, A. (2005) Dehydroepiandrosterone sulfate and allopregnanolone directly stimulate catecholamine production via induction of tyrosine hydroxylase and secretion by affecting actin polymerization. Endocrinology, 146, 3309-3318.
66. Dong, L., Chenga, Z., Fua, Y.-M., Wanga, Z., Zhua, Y.-H., Suna, J., Donga, Y., and Zheng, P. (2007) Neurosteroid dehydroepiandrosterone sulfate enhances spontaneous glutamate release in rat prelimbic cortex through activation of dopamine D1 and sigma-1 receptor. Neuropharmacology, 52, 966-974.
67. Muneoka, K., Iwata, M. and Shirayama, Y. (2009) Altered levels of synapsin I, dopamine transporter, dynorphin A, and neuropeptide Y in the nucleus accumbens and striatum at post-puberty in rats treated neonatally with pregnenolone or DHEA. Int. J. Dev. Neurosci., 27, 575-581.
68. Téllez, N., Comabella, M., Juliá, E., Río, J., Tintoré, M., Brieva, L., Nos, C., and Montalban, X. (2006) Fatigue in progressive multiple sclerosis is associated with low levels of dehydroepiandrosterone. Mult. Scler., 12, 487-494.
69. Regelson, W., Loria, R. and Kalimi, M. (1994) Dehydroepiandrosterone (DHEA) -the ''mother steroid''. I. Immunologic action. Ann. N. Y. Acad. Sci., 19, 553-563.
70. Tan, X.D., Dou, Y., Shi, C., Duan, R. and Sun, R. (2009) Administration of dehydroepiandrosterone ameliorates experimental autoimmune neuritis in Lewis rats. J. Neuroimmunol., 207, 39-44.
71. Du, C., Khalil, M.-W., and Sriram, S. (2001) Administration of dehydroepiandrosterone suppresses experimental allergic encephalomyelitis in SJL/J mice. J. Immunol., 167, 7094-7101.
72. Offner, H., Zamora, A., Drought, H., Matejuk, A., Auci, D.-L., Morgan, E.-E., Vandenbark, A.-A., and Reading, C.-L. (2002) A synthetic androstene derivative and a natural androstene metabolite inhibit relapsing-remitting EAE. J. Neuroimmunol., 130, 113-128.
73. Wang, M., Huang, H., Chen, H., Kuo, J., and Jeng, K. (2001) Dehydroepiandrosterone inhibits lipopolysaccharide-induced nitric oxide production in BV-2 microglia. J. Neurochem., 77, 830-838.
74. Di Santo, E., Foddi, M.C., Ricciardi-Castagnoli, P., Mennini, T., and Ghezzi, P. (1996) DHEAS inhibits TNF production in monocytes, astrocytes and microglial cells. Neuroimmunomodulation, 3, 285-288.
75. Muntwyler, R. and Bologa, L. (1989) In vitro hormonal regulation of astrocyte proliferation. Schweiz. Arch. Neurol. Psychiatr., 140, 29-33.
76. Bologa, L. and Sharma, J. (1987) Dehydroepiandrosterone and its sulfate derivative reduce neuronal death and enhance astrocytic differentiation in brain cell cultures. J. Neurosci. Res., 17, 225-234.
77. Greve, M.W., and Zink, B.J. (2009) Pathophysiology of traumatic brain injury. Mt. Sinai J. Med., 76, 97-104.
78. Li, Z., Cui, S., Zhou, R., Ge, Y., Sokabe, M., and Chen, L. (2009) DHEA-neuroprotection and -neurotoxicity after transient cerebral ischemia in rats. J. Cereb. Blood Flow Metab., 29, 287-296.
79. Hsu, Y., Lapchak, P., Chapman, D., Nunez, S., Zivin, J., and Chung, P. (2000) Possible involvement of GABAA receptors ischemia model: possible involvement of GABAA receptors editorial dehydroepiandrosterone sulfate is neuroprotective in a reversible spinal cord. Stroke, 31, 1953-1957.
80. Bucolo, C. and Drago, F. (2004) Effects of neurosteroids on ischemia-reperfusion injury in the rat retina: role of sigma1 recognition sites. Eur. J. Pharmacol., 498, 111-114.
81. Tabuchi, K., Oikawa, K., Uemaetomari, I., Tsuji, S., Wada, T., and Hara, A. (2003) Glucocorticoids and dehydroepiandrosterone sulfate ameliorate ischemia-induced injury of the cochlea. Hear. Res., 180, 51-56.
82. Aragno, M., Parola, S., Brignardello, E., Mauro, M., Tamagno, E., Manti, R., Danni, O., and Boccuzzi, G. (2000) Dehydroepiandrosterone prevents oxidative injury induced by transient ischemia/reperfusion in the brain of diabetic rats. Diabetes, 49, 1924-1931.
83. Juhasz-Vedres, G., Rozsa, E., Rakos, G., Dobszay, M.-B., Kis, Z., Wolfling, J., Toldi, J., Parducz, R., and Farkas, F. (2006) Dehydroepiandrosterone sulfate is neuroprotective when administered either before or after injury in a focal cortical cold lesion model. Endocrinology, 147, 683-686.
84. Milman, A., Zohar, O., Maayan, R., Weizman, R., and Pick, C. (2008) DHEAS repeated treatment improves cognitive and behavioral deficits after mild traumatic brain injury. Eur. Neuropsychopharmacol., 18, 181-187.
85. Lür, G., Rákos, G., Juhász-Vedres, G., Farkas, T., Kis, Z., and Toldi, J. (2006) Effects of dehydroepiandrosterone sulfate on the evoked cortical activity of controls and of brain-injured rats. Cell. Mol. Neurobiol., 26, 1505-1519.
86. Fiore, C., Inman, D.M., Hirose, S., Noble, L.-J., Igarashi, T. and Compagnone, N.A. (2004) Treatment with the neurosteroid dehydroepiandrosterone promotes recovery of motor behavior after moderate contusive spinal cord injury in the mouse. J. Neurosci. Res., 75, 391-400.
87. Hoffman, S.W., Virmani, S., Simkins, R.M., and Stein, D.G. (2003) The delayed administration of dehydroepiandrosterone sulfate improves recovery of function after traumatic brain injury in rats. J. Neurotrauma., 20, 859-870.
88. Ayhan, S., Markal, N., Siemionow, K., Araneo, B., and Siemionow, M. (2003) Effect of subepineurial dehydroepiandrosterone treatment on healing of transected nerves repaired with the epineurial sleeve technique. Microsurgery, 23, 49-55.
89. García-Estrada, J., Luquín, S., Fernández, A.M. and Garcia-Segura, L.M. (1999) Dehydroepiandrosterone, pregnenolone and sex steroids down-regulate reactive astroglia in the male rat brain after a penetrating brain injury. Int. J. Dev. Neurosci., 17, 145-151.
90. Del Cerro, S., Garcia-Estrada, J., and Garcia-Segura, L.M. (1996) Neurosteroids modulate the reaction of astroglia to high extracellular potassium levels. Glia, 18 (4), 293-305.
91. Malik, A., Narayan, R., Wendling, W., Cole, R., Pashko, L., Schwartz, A., and Strauss, K. (2003) A novel dehydroepiandrosterone analog improves functional recovery in a rat traumatic brain injury model. J. Neurotrauma., 20, 463-476.
92. Liu, D. and Dillon, J.S. (2002) Dehydroepiandrosterone activates endothelial cell nitric-oxide synthase by a specific plasma membrane receptor coupled to Galpha(i2,3). J. Biol. Chem., 277, 21379-21388.
93. Liu, D., Ren, M., Bing, X., Stotts, C., Deorah, S., Love-Homan, L., and Dillon, J.S. (2006) Dehydroepiandrosterone inhibits intracellular calcium release in beta-cells by a plasma membrane-dependent mechanism. Steroids, 71, 691-699.
94. Liu, D., Si, H., Reynolds, K., Zhen, W., Jia, Z., and Dillon, J.S. (2007) Dehydroepiandrosterone protects vascular endothelial cells against apoptosis through a Galphai protein-dependent activation of phosphatidylinositol 3-kinase/Akt and regulation of antiapoptotic Bcl-2 expression. Endocrinology, 148, 3068-3076.
95. Yan, C., Jiang, X., Pei, X., and Dai, Y.R. (1999) The in vitro antiapoptotic effect of dehydroepiandrosterone sulfate in mouse thymocytes and its relation to caspase-3/caspase-6. Cell. Mol. Life Sci., 56, 543-547.
96. Takahashi, H., Nakajima, A., and Sekihara, H. (2004) Dehydroepiandrosterone (DHEA) and its sulfate (DHEAS) inhibit the apoptosis in human peripheral blood lymphocytes. J. Steroid Biochem. Mol. Biol., 88, 261-264.
97. Liang, J., Yao, G., Yang, L., and Hou, Y. (2004) Dehydroepiandrosterone induces apoptosis of thymocyte through Fas/Fas-L pathway. Int. Immunopharmacol., 4, 1467-1475.
98. Alexaki, V.I., Charalampopoulos, I., Panayotopoulou, M., Kampa, M., Gravanis, A., and Castanas, E. (2009) Dehydroepiandrosterone protects human keratinocytes against apoptosis through membrane binding sites. Exp. Cell Res., 315, 2275-2283.
99. Gil-ad, I., Shtaif, B., Eshet, R., Maayan, R., Rehavi, M., and Weizman, A. (2001) Effect of dehydroepiandrosterone and its sulfate metabolite on neuronal cell viability in culture. Isr. Med. Assoc. J., 3, 639-643.
100. Charalampopoulos, I., Tsatsanis, C., Dermitzaki, E., Alexaki, I., Castanas, E., Margioris, A.-N., and Gravanis, A. (2004) Dehydroepiandrosterone and allopregnanolone protect sympathoadrenal cells against apoptosis, via Bcl-2 antiapoptotic proteins. Proc. Natl. Acad. Sci. U.S.A., 101, 8209-8821.
101. Charalampopoulos, I., Alexaki, I.-V., Lazaridis, I., Dermitzaki, E., Avlonitis, N., Tsatsanis, C., Calogeropoulou, T., Margioris, A., Castanas, E., and Gravanis, A. (2006) G-protein-associated membrane binding sites mediate the neuroprotective effect of Dehydroepiandrosterone. FASEB J., 20, 577-579.
102. Reichardt, L.F. (2006) Neurotrophin-regulated signaling pathways. Phil. Trans. R. Soc. B., 361, 1545-1564.
103. Ulmann, L., Rodeau, J., Danoux, L., Contet-Audonneau, J.L., Pauly, G., and Schlichter, R. (2009) Dehydroepiandrosterone and neurotrophins favor axonal growth in a sensory neuron-keratinocyte coculture model. Neuroscience, 159, 514-525.
104. Zhang, B., Li, W., Ma, J., Barker, Y., Chang, W., Zhao, W., and Rubinow, D.R. (2002) Dehydroepiandrosterone (DHEA) and its sulfate derivative (DHEAS) regulate apoptosis during neurogenesis by triggering the Akt signaling pathway in opposing ways. Brain Res. Mol. Brain Res., 98, 58-66.
105. Suzuki, M., Wright, L., Marwah, P., Lardy, H., and Svendsen, C. (2004) Mitotic and neurogenic effects of dehydroepiandrosterone (DHEA) on human neural stem cell cultures derived from the fetal cortex. Proc. Natl. Acad. Sci. U.S.A., 101, 3202-3207.
106. Azizi, H., Mehrjardi, N.Z., Shahbazi, E., Hemmesi, K., Bahmani, M.K., and Baharvand, H. (2010) Dehydroepiandrosterone stimulates neurogenesis in mouse embryonal carcinoma cell-and human embryonic stem cell-derived neural progenitors and induces dopaminergic neurons. Stem Cells Dev, 19, 809-819.
107. Compagnone, N.A. and Mellon, S.H. (1998) Dehydroepiandrosterone: a potential signalling molecule for neocortical organization during development. Proc. Natl. Acad. Sci. U.S.A., 95, 4678-4683.
108. Maninger, N., Wolkowitz, O.M., Reus, V.I., Epel, E.S., and Mellon, S.H. (2009) Neurobiological and neuropsychiatric effects of dehydroepiandrosterone (DHEA) and DHEA sulfate (DHEAS). Front. Neuroendocrinol., 30, 65-91.
109. Bazin, M.A., El Kihel, L., Boulouard, M., Bouët, V., and Rault, S. (2009) The effects of DHEA, 3 beta-hydroxy-5 alpha-androstane-6,17-dione, and 7-amino-DHEA analogues on short term and long term memory in the mouse. Steroids, 74, 931-937.
110. Calogeropoulou, T., Avlonitis, N., Minas, V., Pantzou, A., Alexi, X., Charalampopoulos, I., Zervou, M., Vergou, V., Lazaridis, I., Alexis, M.-N., and Gravanis, A. (2009) Novel dehydroepiandrosterone derivatives with anti-apoptotic, neuroprotective activity. J. Med. Chem., 52, 6569-6587.